A review of health-related quality-of-life concepts and measures for Parkinson's disease Article DOI:
10.1023/A:1008823222574 Cite this article as: Damiano, A.M., Snyder, C., Strausser, B. et al. Qual Life Res (1999) 8: 235. doi:10.1023/A:1008823222574 Abstract
Parkinson's disease affects individuals' health-related quality of life (HQL). Including standardized HQL assessments in therapeutic clinical trials will broaden our understanding of treatment efficacy. Selecting appropriate HQL measures for clinical studies requires consideration of their comprehensiveness, psychometric properties and feasibility. To facilitate selection, this manuscript reviews the HQL areas affected by Parkinson's disease and available Parkinson's disease-specific HQL measures: the Parkinson's Disease Questionnaire-39 (PDQ-39) and the Parkinson's Disease Quality-of-Life Questionnaire (PDQL). Based on a literature review and consultation with HQL experts, five clinicians and three patients, 12 areas of HQL were identified as particularly relevant to Parkinson's disease: physical function, mental health/emotional well being, self-image, social function, health-related distress, cognitive function, communication, sleep and rest, eating, role function, energy/fatigue, and sexual function. The PDQ-39 measures all areas except for self-image and sexual function. The PDQL measures all areas except for eating and role function. Both measures are brief and are designed and validated to be self-completed by patients. Both measures demonstrate adequate internal consistency (PDQ-39: 0.72–0.95; PDQL: 0.80–0.87) and evidence of cross-sectional validity with patient-reported measures of similar concepts. The PDQ-39 also demonstrates reproducibility (0.68–0.94), significant associations with clinical measures and preliminary evidence of responsiveness. Applications of the PDQ-39 and PDQL to clinical trials will contribute greatly towards their continued validation and interpretation.
Health status Health status indicators Parkinson's disease Psychometrics Quality of life References
Amino. MJ. Parkinson's disease and other extrapyra-midal disorders. In: Fauci AS et al. (Eds). Harrison's principles of internal medicine. New York: McGraw-Hill, 1998.
Yahr MD. Parkinsonism. In: Rowland LP (ed). Meritt's Textbook of Neurology. Philadelphia: Lea & Febiger, 1989.
Shindler JS, Brown R, Welburn P, Parkes JD. Measuring the quality of life of patients with Parkinson's disease. In: Walker SR, Rosser RM (Eds). Quality of life assessment: key issues in the 1990's. Dordrecht: Kluwer Academic Publishers, 1993.
Goetz CG, Tanner CM, Penn RD et al. Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psy-chomotor data. Neurology 1990; 40: 273±276.
Sano M, Stern Y, Marder K, Mayeux R. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease. Movement Disorders 1990; 5: 230±234.
Nunnally JC, Psychometric theory. New York: Mc-Graw-Hill, 1978.
Ware JE. Methodological considerations in the selec-tion of health status assessment procedures. In: Wenger NK, Mattson ME, Furberg CD, Elinson J (Eds). As-sessment of quality of life in clinical trials of cardio-vascular therapies. Le Jacq, 1984.
Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale: Lawrence Erlbaum Associ-ates, 1988.
Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with de-pression. Biol Psychiatry 1993; 34: 465±470.
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Par-kinson's disease. Quality of Life Res 1995; 4: 241±248.
Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hy-man N.Self-reported functioning and well being in patients with Parkinson's disease: comparison of the Short-Form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age and Geing 1995; 24: 505±509.
Hutton JT, Knoller WC, Ahlskog JE et al. Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease. Neurology 1996; 46: 1062±1065.
Fitzsimmons B, Bunting LK. Parkinson's disease ± quality of life issues. Neurosci Nursing 1993; 4: 807±818.
Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Behav Neurol Movement Dis 1995; 65: 115±138.
Stallibrass C. An evaluation of the Alexander Tech-nique for the management of disability in Parkinson's disease ± a preliminary study. Clinical Rehabilitation 1997; 11: 8±12.
de Boer AGEM, Wijker W, Speelman JD, de Haes JCJM. Quality of life in patients with Parkinson's dis-ease: development of a questionnaire.J Neurol, Ne-urosurg Psychiatry 1996; 61: 70±74.
Welsh M, McDermott M, Holloway R, Plumb S, Pfeiffer R, Hubble J. Development and testing of the Parkinson's Disease Quality of Life Scale: The PDQUALIF [Abstract]. Movement Dis 1997; 12: 836.
Jenkinson C, Peto V, Fitzpatrick R. The Parkinson's disease questionnaire: user manual for the PDQ-39, PDQ-8 and PDQ-summary index. Health Services Re-search Unit, University of Oxford, 1998.
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hy-man N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psy-chology and Health 1997; 12: 805±814.
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hy-man N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's dis-ease summary index score. Age and Ageing 1997; 26: 353±357.
Bushnell DM, Martin ML, Grippi J. The translation and validation of a quality of life instrument for Par-kinson's disease [Abstract]. Drug Inform J 1997; 31: 1412±1413.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health survey manual and interpretation guide. Bos-ton: The Health Institute, New England Medical Cen-ter, 1993.
Fitzpatrick R, Peto V, Jenkinson C, Greenhall R, Hy-man N. Health-related quality of life in Parkinson's disease: a study of out-patient clinic attenders. Move-ment Dis 1997; 12: 916±922. 24. Peto V, Fitzpatrick R, Jenkinson C. Self-reported health status and access to health services in a com-munity sample with Parkinson's disease. Disability and Rehab 1997; 19: 97±103.
Peto V, Fitzpatrick R, Jenkinson C. Self-reportedhealth status and access to health services in a community sample with Parkinson's disease. Disability and Rehab 1997; 19: 97–103.
Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FF, Donaldson MC (Eds). Third symposium on Parkinson's disease. Edinburgh: Livingstone, 1969.
Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a pa-tient population. Med Care 1988; 26: 724±35.
Radlo. LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measur 1977; 1: 385±401.
Sherbourne CD, Stewart AL. The MOS social support survey. Social Sci and Medicine 1991; 32: 705±714.
Fitzpatrick R, Jenkinson C, Peto V, Hyman N, Greenhall R. Desirable properties for instruments as-sessing quality of life: evidence from the PDQ-39. J Neuro, Neurosurg and Psychiatry 1997; 62: 104.
Sherbourne CD. Social functioning: sexual problems measures. In: Stewart, AL, Ware, JE (Eds). Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University Press, 1992.
Google Scholar Copyright information
© Kluwer Academic Publishers 1999